| 1 |
What is the primary function of AI in the medical imaging industry?
|
To improve diagnostic accuracy and patient outcomes |
|
according to the background , AI technology has the potential to revolutionize medical practice. |
According to the sources, the primary function of Artificial Intelligence (AI) in the medical imaging industry is its potential to transform medical practice. This transformation aims to materially improve productivity and patient outcomes. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
Which of the following is a key benefit of AI in radiology noted in the article?
|
Acts as a second medical opinion |
|
according to the topic about motivation |
AI's capability to assist in diagnosis can function similarly to a "second opinion" by offering additional analysis or confirmation, thereby contributing to improved diagnostic accuracy and ultimately better patient outcomes. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
What does AI literacy refer to according to the article?
|
Understanding and knowledge of AI technology |
|
According to the sources, AI literacy refers to a user factor that influences the acceptability of Artificial Intelligence among healthcare professionals in medical imaging domains. |
This implies that healthcare professionals will have different levels of familiarity and comprehension regarding AI technology, and successful AI implementation depends on systems that accommodate this range of knowledge |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
Which factor is NOT listed as influencing the acceptability of AI among healthcare professionals?
|
The color of the AI machines |
|
according to the results |
According to the study, the factors influencing the acceptability of AI among healthcare professionals in medical imaging domains are categorized into three overarching groups , which not including the color of the AI . |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
What role does social influence play in AI acceptability in healthcare according to the article?
|
Affects healthcare professionals’ decisions to use AI |
|
according to Fig. 2. Distribution of factors influencing healthcare professional acceptability of AI in the primary studies. |
The literature identifies social influence as one of the "socio-organisational-cultural factors" that underpin AI acceptability . Therefore, social influence, as a factor contributing to AI acceptability, affects healthcare professionals’ decisions to use AI |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
What is a perceived threat regarding AI usage in healthcare settings?
|
Concerns about replacing healthcare professionals |
|
according to 4.3. Theoretical frameworks and ad-hoc approaches used |
Based on the provided sources, a perceived threat regarding AI usage in healthcare settings includes a perceived threat to professional identity . |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
According to the article, what is essential for increasing AI acceptability among medical professionals?
|
Designing human-centred AI systems |
|
according to the conclusion |
According to the sources, designing human-centred AI systems is essential for increasing AI acceptability among medical professionals.
This approach is critical and extends beyond merely achieving high algorithmic performance. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
What does the 'system usage' category of AI acceptability factors include according to the article?
|
Factors like value proposition and integration with workflows |
|
according to Table 1. Characteristics of the studies included in the scoping review. |
According to the sources, the 'system usage' category of AI acceptability factors includes value proposition, self-efficacy, burden, and workflow integration.These factors are part of the three overarching categories that underpin AI acceptability among healthcare professionals in medical imaging domains. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
How does ethicality impact AI acceptability among healthcare professionals?
|
Affects views on AI based on compatibility with professional values |
|
according to the conclusion |
According to the sources, ethicality significantly impacts AI acceptability among healthcare professionals because it affects views on AI based on compatibility with professional values. Therefore, for AI systems to be accepted by medical professionals, their design and deployment must align with the established ethical standards and values of the healthcare profession |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
What methodological approach did the article emphasize for future AI acceptability studies?
|
Considering user experience and system integration deeply |
|
according to the conclusion |
future work should aim to synthesize evidence on the causal importance of different factors in achieving high medical AI acceptance and modify existing theoretical frameworks to better capture the complexities of AI deployment in healthcare contexts |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
What is the primary objective of using human embryonic stem cells in treating Parkinson’s disease?
|
To replace lost dopamine neurons. |
|
According to the summary, cell replacement therapy is replacing dopaminergic neurons. |
Preclinical studies have shown that these transplanted cells can mediate full functional recovery in a rat model of PD. A clinical trial using a fully in vivo-tested batch of STEM-PD was initiated in 2022 for patients with moderate PD. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
Which animal was used to test the STEM-PD product for safety and efficacy?
|
Rats |
|
according to the Manufacturing and quality control of STEM-PD . |
Preclinical studies have shown that these transplanted cells can mediate full functional recovery in a rat model of PD. A clinical trial using a fully in vivo-tested batch of STEM-PD was initiated in 2022 for patients with moderate PD. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
What was the duration of the preclinical safety study in rats mentioned in the article?
|
9 months |
|
according to the Figure 2. GLP safety study for toxicity, tumorigenicity, and biodistribution |
The preclinical safety study in rats, mentioned in the sources regarding the human embryonic stem cell-derived product STEM-PD for Parkinson's disease, had a duration of 39 weeks. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
What is the name of the clinical trial phase mentioned for STEM-PD?
|
Phase I/IIa |
|
according to the summary |
The clinical trial phase mentioned for STEM-PD is phase I/IIa. This is described as a first-in-human clinical trial. The trial involves 8 patients with moderate Parkinson's disease and was initiated in 2022. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
How is the STEM-PD product manufactured?
|
Under GMP-compliant conditions |
|
according to the summary |
The STEM-PD product is manufactured under GMP (Good Manufacturing Practice). It is a cryopreserved dopamine progenitor cell product that is derived from human embryonic stem cells (hESCs). |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
According to the article, what confirmed the safety of the STEM-PD product in rats?
|
There were no adverse effects or tumor formation. |
|
according to the Figure 2. GLP safety study for toxicity, tumorigenicity, and biodistribution |
The product underwent a 39-week rat GLP (Good Laboratory Practice) safety study. This study assessed the product for toxicity, tumorigenicity, and biodistribution, and the crucial finding was that no adverse effects were observed. This also means that no tumor formation was seen up to 9 months.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
What key finding was noted in the efficacy study of STEM-PD in rats?
|
Transplanted cells reversed motor deficits in rats. |
|
According to the summary |
A non-GLP (Good Laboratory Practice) efficacy study confirmed that the transplanted STEM-PD cells mediated full functional recovery in a preclinical rat model of Parkinson's disease. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What specific markers were used to assess the purity of the STEM-PD batch?
|
FOXA2 and OTX2 |
|
according to Table 1. STEM-PD release specification and results |
to test the purity or to identify use flow cytometry: FOXA2 and OTX2 |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
What role do growth factors like FGF8b and SHH play in the manufacturing process of STEM-PD?
|
They prevent differentiation. |
|
according to the study of Fibroblast growth factor 8: Multifaceted role in development and developmental disorder |
Fibroblast growth factor 8 (FGF8), a secreted signaling molecule, involves in regulating cell survival, proliferation, migration, and differentiation. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
What was a key outcome measured in the preclinical trials for efficacy in rats?
|
Recovery of motor function |
|
according to the summary |
Specifically, a non-GLP (Good Laboratory Practice) efficacy study confirmed that the transplanted STEM-PD cells mediated full functional recovery in a preclinical rat model of Parkinson's disease. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|